Rationale:
Gain of function (GOF) mutations in
PIK3CD
gene encoding PI3K p110δ were recently associated with a novel combined immune deficiency characterized by recurrent sinopulmonary infections, CD
4
+
lymphopenia, reduced class-switched memory B cells, lymphadenopathy, cytomegalovirus and/or epstein-Barr virus (EBV) viremia, and EBV-related lymphoma. A subset of affected patients also had elevated serum IgM.
Patient concerns:
We report a patient who was diagnosed with systemic lupus erythematosus (SLE) at a young age and was recently found to carry heterozygous mutations in
PIK3CD
. The patient not only presented with recurrent sinopulmonary infections, CD
4
+
lymphopenia, lymphadenopathy, EBV viremia, and elevated serum IgM, but also met classification criteria of SLE based on persistent proteinuria and hematuria, leukopenia and anemia, low level of serum complement, and positive autoantibody for antinuclear antibodies.
Diagnoses:
Activated PI3Kδ syndrome.
Interventions:
Oral prednisolone and hydroxychloroquine combined with mycophenolate mofetil was given to the patient. He was currently receiving intravenous immunoglobulin per month in association with hydroxychloroquine, low-dose prednisolone, and mycophenolate mofetil.
Outcomes:
At present, the level of complement restored to normal, hematuria and proteinuria disappeared, and liver function returned to normal.
Lessons:
SLE may be a novel phenotype of GOF mutation in
PI3CKD
gene (GOF PIK3CD).